VREX vs. SLN, SVRA, ZYME, MLAB, AUNA, ENGN, DH, AVBP, SIBN, and QTRX
Should you be buying Varex Imaging stock or one of its competitors? The main competitors of Varex Imaging include Silence Therapeutics (SLN), Savara (SVRA), Zymeworks (ZYME), Mesa Laboratories (MLAB), Auna (AUNA), enGene (ENGN), Definitive Healthcare (DH), ArriVent BioPharma (AVBP), SI-BONE (SIBN), and Quanterix (QTRX). These companies are all part of the "medical" sector.
Varex Imaging (NASDAQ:VREX) and Silence Therapeutics (NASDAQ:SLN) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, valuation, dividends, media sentiment, profitability, institutional ownership, community ranking, analyst recommendations and risk.
98.7% of Silence Therapeutics shares are owned by institutional investors. 5.2% of Varex Imaging shares are owned by company insiders. Comparatively, 3.0% of Silence Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Varex Imaging has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Comparatively, Silence Therapeutics has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500.
Varex Imaging has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.
Varex Imaging received 208 more outperform votes than Silence Therapeutics when rated by MarketBeat users. However, 71.88% of users gave Silence Therapeutics an outperform vote while only 63.46% of users gave Varex Imaging an outperform vote.
Varex Imaging presently has a consensus target price of $27.00, suggesting a potential upside of 80.36%. Silence Therapeutics has a consensus target price of $57.25, suggesting a potential upside of 148.91%. Given Silence Therapeutics' higher possible upside, analysts clearly believe Silence Therapeutics is more favorable than Varex Imaging.
Varex Imaging has a net margin of 4.90% compared to Silence Therapeutics' net margin of -131.44%. Varex Imaging's return on equity of 8.26% beat Silence Therapeutics' return on equity.
In the previous week, Silence Therapeutics had 9 more articles in the media than Varex Imaging. MarketBeat recorded 10 mentions for Silence Therapeutics and 1 mentions for Varex Imaging. Silence Therapeutics' average media sentiment score of 0.66 beat Varex Imaging's score of 0.00 indicating that Silence Therapeutics is being referred to more favorably in the news media.
Summary
Varex Imaging beats Silence Therapeutics on 9 of the 17 factors compared between the two stocks.
Get Varex Imaging News Delivered to You Automatically
Sign up to receive the latest news and ratings for VREX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding VREX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Varex Imaging Competitors List
Related Companies and Tools
